Effects of Pre- or Post-Exercise Low-Level Laser Therapy (830 nm) on Skeletal Muscle Fatigue and Biochemical Markers of Recovery in Humans: Double-Blind Placebo-Controlled Trial

2014 ◽  
Vol 32 (2) ◽  
pp. 106-112 ◽  
Author(s):  
Filipe Abdalla dos Reis ◽  
Baldomero Antonio Kato da Silva ◽  
Erica Martinho Salvador Laraia ◽  
Rhaiza Marques de Melo ◽  
Patrícia Henrique Silva ◽  
...  
2016 ◽  
Vol 31 (9) ◽  
pp. 1935-1942 ◽  
Author(s):  
Carolina Gassen Fritsch ◽  
Maurício Pinto Dornelles ◽  
Lucas Severo-Silveira ◽  
Vanessa Bernardes Marques ◽  
Isabele de Albuquerque Rosso ◽  
...  

Author(s):  
Amanda Soares Felismino ◽  
Eduardo Caldas Costa ◽  
Marcelo Saldanha Aoki ◽  
Cleber Ferraresi ◽  
Telma Maria de Araújo Moura Lemos ◽  
...  

2009 ◽  
Vol 108 (6) ◽  
pp. 1083-1088 ◽  
Author(s):  
Ernesto Cesar Pinto Leal Junior ◽  
Rodrigo Álvaro Brandão Lopes-Martins ◽  
Patrícia de Almeida ◽  
Luciano Ramos ◽  
Vegard V. Iversen ◽  
...  

2016 ◽  
Vol 32 (1) ◽  
pp. 251-251
Author(s):  
Carolina Gassen Fritsch ◽  
Maurício Pinto Dornelles ◽  
Lucas Severo-Silveira ◽  
Vanessa Bernardes Marques ◽  
Isabele de Albuquerque Rosso ◽  
...  

VASA ◽  
2002 ◽  
Vol 31 (2) ◽  
pp. 91-94 ◽  
Author(s):  
Hirschl ◽  
Katzenschlager ◽  
Ammer ◽  
Melnizky ◽  
Rathkolb ◽  
...  

Background: No causal treatment of primary Raynaud’s phenomenon is available due to its unclear aetiology. Low level laser therapy (LLLT) is applied in a multitude of medical conditions often without sufficient evidence of efficacy and established mechanisms. To asses the effect of this therapy in patients with primary Raynaud’s phenomenon a randomised, double blind, placebo controlled cross over study was designed. Patients and methods: Absolute and relative frequency and intensity of vasospastic attacks during three weeks of either LLLT or placebo therapy and results of infrared thermography before onset and at the end of both therapy sequences were evaluated in 15 patients with primary Raynaud’s phenomenon. Results: Frequency of Raynaud’s attacks was not significantly affected by low level laser therapy. Compared to placebo a significantly lower intensity of attacks during laser irradiation was observed, but no transfer effect occurred. Additionally the mean temperature gradient after cold exposure was reduced after laser irradiation, while the number of fingers showing prolonged rewarming was unaffected. Conclusion: Though further studies are necessary to confirm these results we could demonstrate for the first time in a double blind placebo controlled clinical trial that low laser therapy is a potential candidate for an effective therapy of Raynaud`s phenomenon, although effects seem to be of short duration.


2008 ◽  
Vol 24 (3) ◽  
pp. 425-431 ◽  
Author(s):  
Ernesto Cesar Pinto Leal Junior ◽  
Rodrigo Álvaro Brandão Lopes-Martins ◽  
Adriane Aver Vanin ◽  
Bruno Manfredini Baroni ◽  
Douglas Grosselli ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document